- Home
- LNAI vs REE Comparison
LNAI vs REE Comparison
Compare LNAI & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNAI
- REE
- Stock Information
- Founded
- LNAI N/A
- REE 2011
- Country
- LNAI United States
- REE Israel
- Employees
- LNAI N/A
- REE N/A
- Industry
- LNAI Biotechnology: Pharmaceutical Preparations
- REE Auto Manufacturing
- Sector
- LNAI Health Care
- REE Consumer Discretionary
- Exchange
- LNAI Nasdaq
- REE Nasdaq
- Market Cap
- LNAI 23.9M
- REE 22.4M
- IPO Year
- LNAI N/A
- REE N/A
- Fundamental
- Price
- LNAI $1.25
- REE $0.74
- Analyst Decision
- LNAI
- REE Strong Buy
- Analyst Count
- LNAI 0
- REE 2
- Target Price
- LNAI N/A
- REE $11.75
- AVG Volume (30 Days)
- LNAI 9.2M
- REE 128.7K
- Earning Date
- LNAI 11-14-2025
- REE 12-16-2025
- Dividend Yield
- LNAI N/A
- REE N/A
- EPS Growth
- LNAI N/A
- REE N/A
- EPS
- LNAI N/A
- REE N/A
- Revenue
- LNAI N/A
- REE $183,000.00
- Revenue This Year
- LNAI N/A
- REE $327.73
- Revenue Next Year
- LNAI N/A
- REE $36,888.82
- P/E Ratio
- LNAI N/A
- REE N/A
- Revenue Growth
- LNAI N/A
- REE N/A
- 52 Week Low
- LNAI $0.81
- REE $0.53
- 52 Week High
- LNAI $21.00
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- LNAI N/A
- REE 37.61
- Support Level
- LNAI N/A
- REE $0.66
- Resistance Level
- LNAI N/A
- REE $0.99
- Average True Range (ATR)
- LNAI 0.00
- REE 0.11
- MACD
- LNAI 0.00
- REE -0.02
- Stochastic Oscillator
- LNAI 0.00
- REE 22.23
About LNAI Lunai Bioworks Inc. Common Stock
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.